TipRanks on MSN

Cynata Therapeutics Secures $1.7 Million R&D Tax Refund to Boost Cell Therapy Development

Cynata Therapeutics Limited ( (AU:CYP) ) has issued an announcement. Cynata Therapeutics Limited announced it received a $1.7 million R&D Tax Incentive Refund for the 2024/2025 financial year. This ...

Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update

On track for top-line trial results in the third quarter of 2026 from pivotal Phase 2b clinical trial ELPIS II. ELPIS II is evaluating ...